secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K/A
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001193125-25-312912
Event type: regulatory
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galecto corrects Series C Preferred Stock authorization from 43,855 to 43,882 shares
--------------------------------------------------------------------------------

- Filed Certificate of Correction on Dec 5, 2025 to fix inadvertent error in Series C Preferred Stock designation.
- Authorized shares revised to 43,882 from incorrectly stated 43,855; no other terms changed.
- Amendment amends 8-K originally filed Nov 10, 2025; restated certificate attached as Exhibit 3.3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000119312525312912/0001193125-25-312912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000119312525312912/glto-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-312912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer